ICD1890K.m

ICD1890K ;ALB/JDG - YEARLY DRG UPDATE;8/1/2016

 ;;18.0;DRG Grouper;**90**;Oct 20, 2000;Build 13

 ;

 ; Updates for DRGS 810-999

 Q

 ;

MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS

 ;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^.9387^2.8

 ;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.3352^3.7

 ;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^.8632^2.8

 ;;813^16^MED^COAGULATION DISORDERS^1.9246^3.7

 ;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.7033^4.8

 ;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^.9629^3.2

 ;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^.7358^2.4

 ;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^5.9142^12.0

 ;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3309^4.5

 ;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.2134^2.0

 ;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W MCC^4.4304^10.8

 ;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W CC^2.2564^5.8

 ;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W/O CC/MCC^1.3561^3.0

 ;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^4.8686^10.7

 ;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.3484^5.0

 ;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.4739^2.8

 ;;829^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W CC/MCC^3.3552^7.0

 ;;830^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W/O CC/MCC^1.5046^3.0

 ;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^5.6316^10.1

 ;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.2517^4.8

 ;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.2096^2.9

 ;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^6.0067^15.2

 ;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^2.6237^6.5

 ;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.3501^4.8

 ;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^3.1216^7.5

 ;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6931^4.7

 ;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.1365^3.0

 ;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.8032^5.5

 ;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.1817^4.0

 ;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^.8519^2.9

 ;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.4663^6.0

 ;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.2507^3.5

 ;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^.9131^2.9

 ;;849^17^MED^RADIOTHERAPY^1.7519^5.0

 ;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.1097^10.5

 ;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.3655^6.4

 ;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.5640^3.6

 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.6425^9.6

 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.0786^5.6

 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.4545^4.0

 ;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.8151^5.3

 ;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^.9903^3.7

 ;;864^18^MED^FEVER^.8385^2.8

 ;;865^18^MED^VIRAL ILLNESS W MCC^1.3267^4.0

 ;;866^18^MED^VIRAL ILLNESS W/O MCC^.7676^2.7

 ;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.6467^6.7

 ;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.0595^3.7

 ;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^.6640^2.6

 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV >96 HOURS^5.8960^12.6

 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC^1.7660^4.9

 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W/O MCC^1.0283^3.8

 ;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^3.4193^7.9

 ;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^.7404^2.5

 ;;881^19^MED^DEPRESSIVE NEUROSES^.6677^3.5

 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^.7307^3.4

 ;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.2851^4.5

 ;;884^19^MED^ORGANIC DISTURBANCES & INTELLECTUAL DISABILITY^1.1753^4.3

 ;;885^19^MED^PSYCHOSES^1.0938^5.6

 ;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^.8339^4.2

 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.0077^2.9

 ;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^.4852^2.1

 ;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.2914^9.4

 ;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.6098^4.9

 ;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^.7481^3.4

 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^4.3264^9.2

 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.8916^5.2

 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.1114^3.2

 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^3.2625^7.4

 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.3798^3.4

 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.5037^3.0

 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^3.8681^7.4

 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^2.0584^4.4

 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.3110^2.6

 ;;913^21^MED^TRAUMATIC INJURY W MCC^1.2511^3.6

 ;;914^21^MED^TRAUMATIC INJURY W/O MCC^.7634^2.5

 ;;915^21^MED^ALLERGIC REACTIONS W MCC^1.6001^3.8

 ;;916^21^MED^ALLERGIC REACTIONS W/O MCC^.5955^1.8

 ;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4307^3.5

 ;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^.7115^2.3

 ;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.7730^4.5

 ;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^1.0074^3.1

 ;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^.6950^2.2

 ;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.4439^3.8

 ;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^.8218^2.5

 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W SKIN GRAFT^14.4493^22.3

 ;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^5.1947^10.4

 ;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.5587^5.5

 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W/O SKIN GRAFT^3.1252^2.4

 ;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.6575^4.1

 ;;935^22^MED^NON-EXTENSIVE BURNS^1.6635^3.5

 ;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^3.3068^6.7

 ;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^1.9740^3.8

 ;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.4341^2.3

 ;;945^23^MED^REHABILITATION W CC/MCC^1.2234^8.7

 ;;946^23^MED^REHABILITATION W/O CC/MCC^1.0534^7.1

 ;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.1364^3.6

 ;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^.7463^2.7

 ;;949^23^MED^AFTERCARE W CC/MCC^.9442^3.0

 ;;950^23^MED^AFTERCARE W/O CC/MCC^.5660^2.3

 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^.9244^2.6

 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^5.4840^7.5

 ;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.8187^6.5

 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^6.8917^9.7

 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^3.8591^7.1

 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.5275^4.2

 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.5822^5.3

 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.4177^4.1

 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^.9686^2.9

 ;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.8763^11.5

 ;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.4171^5.8

 ;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.6672^6.6

 ;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.2730^4.3

 ;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^.8784^3.2

 ;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.2405^3.6

 ;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^4.9451^9.6

 ;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.7320^5.4

 ;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.7815^2.7

 ;;984^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.4109^8.7

 ;;985^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.8073^4.5

 ;;986^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.1128^2.3

 ;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.3271^8.3

 ;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.7171^4.5

 ;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0564^2.2

 ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0000^0.0

 ;;999^99^**^UNGROUPABLE^0.0000^0.0

 ;;EXIT

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---ICD1890K   9303     printed  Apr 23, 2025@18:03:54                                                                                                                                                                                                    Page 2

ICD1890K  ;ALB/JDG - YEARLY DRG UPDATE;8/1/2016

 +1       ;;18.0;DRG Grouper;**90**;Oct 20, 2000;Build 13

 +2       ;

 +3       ; Updates for DRGS 810-999

 +4        QUIT 

 +5       ;

MSDRG     ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS

 +1       ;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^.9387^2.8

 +2       ;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.3352^3.7

 +3       ;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^.8632^2.8

 +4       ;;813^16^MED^COAGULATION DISORDERS^1.9246^3.7

 +5       ;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.7033^4.8

 +6       ;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^.9629^3.2

 +7       ;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^.7358^2.4

 +8       ;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^5.9142^12.0

 +9       ;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.3309^4.5

 +10      ;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.2134^2.0

 +11      ;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W MCC^4.4304^10.8

 +12      ;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W CC^2.2564^5.8

 +13      ;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W/O CC/MCC^1.3561^3.0

 +14      ;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^4.8686^10.7

 +15      ;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.3484^5.0

 +16      ;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.4739^2.8

 +17      ;;829^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W CC/MCC^3.3552^7.0

 +18      ;;830^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W/O CC/MCC^1.5046^3.0

 +19      ;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^5.6316^10.1

 +20      ;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.2517^4.8

 +21      ;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^1.2096^2.9

 +22      ;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^6.0067^15.2

 +23      ;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^2.6237^6.5

 +24      ;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^1.3501^4.8

 +25      ;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^3.1216^7.5

 +26      ;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6931^4.7

 +27      ;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.1365^3.0

 +28      ;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.8032^5.5

 +29      ;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.1817^4.0

 +30      ;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^.8519^2.9

 +31      ;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^2.4663^6.0

 +32      ;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.2507^3.5

 +33      ;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^.9131^2.9

 +34      ;;849^17^MED^RADIOTHERAPY^1.7519^5.0

 +35      ;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.1097^10.5

 +36      ;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^2.3655^6.4

 +37      ;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^1.5640^3.6

 +38      ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^4.6425^9.6

 +39      ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.0786^5.6

 +40      ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^1.4545^4.0

 +41      ;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.8151^5.3

 +42      ;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^.9903^3.7

 +43      ;;864^18^MED^FEVER^.8385^2.8

 +44      ;;865^18^MED^VIRAL ILLNESS W MCC^1.3267^4.0

 +45      ;;866^18^MED^VIRAL ILLNESS W/O MCC^.7676^2.7

 +46      ;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.6467^6.7

 +47      ;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.0595^3.7

 +48      ;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^.6640^2.6

 +49      ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS W MV >96 HOURS^5.8960^12.6

 +50      ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC^1.7660^4.9

 +51      ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W/O MCC^1.0283^3.8

 +52      ;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^3.4193^7.9

 +53      ;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^.7404^2.5

 +54      ;;881^19^MED^DEPRESSIVE NEUROSES^.6677^3.5

 +55      ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^.7307^3.4

 +56      ;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^1.2851^4.5

 +57      ;;884^19^MED^ORGANIC DISTURBANCES & INTELLECTUAL DISABILITY^1.1753^4.3

 +58      ;;885^19^MED^PSYCHOSES^1.0938^5.6

 +59      ;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^.8339^4.2

 +60      ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.0077^2.9

 +61      ;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^.4852^2.1

 +62      ;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^1.2914^9.4

 +63      ;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.6098^4.9

 +64      ;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^.7481^3.4

 +65      ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^4.3264^9.2

 +66      ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.8916^5.2

 +67      ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.1114^3.2

 +68      ;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^3.2625^7.4

 +69      ;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.3798^3.4

 +70      ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.5037^3.0

 +71      ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^3.8681^7.4

 +72      ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^2.0584^4.4

 +73      ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.3110^2.6

 +74      ;;913^21^MED^TRAUMATIC INJURY W MCC^1.2511^3.6

 +75      ;;914^21^MED^TRAUMATIC INJURY W/O MCC^.7634^2.5

 +76      ;;915^21^MED^ALLERGIC REACTIONS W MCC^1.6001^3.8

 +77      ;;916^21^MED^ALLERGIC REACTIONS W/O MCC^.5955^1.8

 +78      ;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.4307^3.5

 +79      ;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^.7115^2.3

 +80      ;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.7730^4.5

 +81      ;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^1.0074^3.1

 +82      ;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^.6950^2.2

 +83      ;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.4439^3.8

 +84      ;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^.8218^2.5

 +85      ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W SKIN GRAFT^14.4493^22.3

 +86      ;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^5.1947^10.4

 +87      ;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.5587^5.5

 +88      ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV >96 HRS W/O SKIN GRAFT^3.1252^2.4

 +89      ;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.6575^4.1

 +90      ;;935^22^MED^NON-EXTENSIVE BURNS^1.6635^3.5

 +91      ;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^3.3068^6.7

 +92      ;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^1.9740^3.8

 +93      ;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.4341^2.3

 +94      ;;945^23^MED^REHABILITATION W CC/MCC^1.2234^8.7

 +95      ;;946^23^MED^REHABILITATION W/O CC/MCC^1.0534^7.1

 +96      ;;947^23^MED^SIGNS & SYMPTOMS W MCC^1.1364^3.6

 +97      ;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^.7463^2.7

 +98      ;;949^23^MED^AFTERCARE W CC/MCC^.9442^3.0

 +99      ;;950^23^MED^AFTERCARE W/O CC/MCC^.5660^2.3

 +100     ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^.9244^2.6

 +101     ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^5.4840^7.5

 +102     ;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.8187^6.5

 +103     ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^6.8917^9.7

 +104     ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^3.8591^7.1

 +105     ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^2.5275^4.2

 +106     ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.5822^5.3

 +107     ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.4177^4.1

 +108     ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^.9686^2.9

 +109     ;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.8763^11.5

 +110     ;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^2.4171^5.8

 +111     ;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.6672^6.6

 +112     ;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.2730^4.3

 +113     ;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^.8784^3.2

 +114     ;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.2405^3.6

 +115     ;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^4.9451^9.6

 +116     ;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.7320^5.4

 +117     ;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.7815^2.7

 +118     ;;984^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.4109^8.7

 +119     ;;985^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.8073^4.5

 +120     ;;986^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.1128^2.3

 +121     ;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^3.3271^8.3

 +122     ;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^1.7171^4.5

 +123     ;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.0564^2.2

 +124     ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0000^0.0

 +125     ;;999^99^**^UNGROUPABLE^0.0000^0.0

 +126     ;;EXIT